Piprazat combines Piperacillin and Tazobactam to treat severe resistant infections including sepsis, intra-abdominal infections, pneumonia, UTI complications, and hospital-acquired infections.
It is used in ICU and high-dependency settings for broad resistant bacterial coverage.
Reviews
There are no reviews yet.